Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
62,000
-33.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rangeley Capital, LLC holds $628,000 across 2 Drug Manufacturers - Specialty & Generic names. ESPR ranks #2 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
20,000 | $628,000 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
This page
|
62,000 | $0 |
All Filings in ESPR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 62,000 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | — | 92,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | — | 107,000 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||